Normal IPT and IBZM SPECT in drug naive and levodopa-treated idiopathic restless legs syndrome.

作者信息

Tribl G G, Asenbaum S, Klösch G, Mayer K, Bonelli R M, Auff E, Zeitlhofer J, Happe S

出版信息

Neurology. 2002 Aug 27;59(4):649-50. doi: 10.1212/wnl.59.4.649.

DOI:10.1212/wnl.59.4.649

PMID:12196677

Abstract

摘要

相似文献

Normal IPT and IBZM SPECT in drug naive and levodopa-treated idiopathic restless legs syndrome.

Neurology. 2002 Aug 27;59(4):649-50. doi: 10.1212/wnl.59.4.649.

Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome.

Neurology. 2001 Oct 9;57(7):1307-9. doi: 10.1212/wnl.57.7.1307.

Normal striatal D2 receptor binding in idiopathic restless legs syndrome with periodic leg movements in sleep.

Nucl Med Commun. 2004 Jan;25(1):55-60. doi: 10.1097/00006231-200401000-00008.

IBZM-SPECT as predictor for dopamimetic responsiveness of patients with de novo parkinsonian syndrome.

Adv Neurol. 1993;60:519-24.

Clinical and [99mTc]TRODAT-1/[123I]IBZM SPECT imaging findings in dopa-responsive dystonia.

Eur Neurol. 2004;51(1):26-9. doi: 10.1159/000074914. Epub 2003 Nov 18.

[123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.

Am J Psychiatry. 1996 Feb;153(2):183-90. doi: 10.1176/ajp.153.2.183.

Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome.

Lancet Neurol. 2006 Oct;5(10):878-86. doi: 10.1016/S1474-4422(06)70576-2.

Computerized movement analysis and beta-CIT-SPECT in patients with restless legs syndrome.

J Neural Transm (Vienna). 2005 May;112(5):693-701. doi: 10.1007/s00702-004-0217-9. Epub 2004 Oct 27.

Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: technical and interobserver variability.

J Nucl Med. 1993 Dec;34(12):2076-84.

Dopamine D2 receptor imaging with iodine-123-iodobenzamide SPECT in idiopathic rotational torticollis.

J Nucl Med. 1994 Dec;35(12):1921-7.

引用本文的文献

Brain-iron deficiency models of restless legs syndrome.

Exp Neurol. 2022 Oct;356:114158. doi: 10.1016/j.expneurol.2022.114158. Epub 2022 Jun 30.

Brain imaging and networks in restless legs syndrome.

Sleep Med. 2017 Mar;31:39-48. doi: 10.1016/j.sleep.2016.07.018. Epub 2016 Aug 29.

Genetic markers of Restless Legs Syndrome in Parkinson disease.

Parkinsonism Relat Disord. 2015 Jun;21(6):582-5. doi: 10.1016/j.parkreldis.2015.03.010. Epub 2015 Mar 17.

Imaging brain functional and metabolic changes in restless legs syndrome.

Curr Neurol Neurosci Rep. 2013 Sep;13(9):372. doi: 10.1007/s11910-013-0372-1.

Increased synaptic dopamine in the putamen in restless legs syndrome.

Sleep. 2013 Jan 1;36(1):51-7. doi: 10.5665/sleep.2300.

Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome.

Brain. 2009 Sep;132(Pt 9):2403-12. doi: 10.1093/brain/awp125. Epub 2009 May 25.

Restless legs syndrome: pathophysiology, diagnosis and treatment.

CNS Drugs. 2008;22(6):497-518. doi: 10.2165/00023210-200822060-00004.

Abnormally increased CSF 3-Ortho-methyldopa (3-OMD) in untreated restless legs syndrome (RLS) patients indicates more severe disease and possibly abnormally increased dopamine synthesis.

Sleep Med. 2009 Jan;10(1):123-8. doi: 10.1016/j.sleep.2007.11.012. Epub 2008 Jan 28.

Apomorphine in idiopathic restless legs syndrome: an exploratory study.

J Neurol Neurosurg Psychiatry. 2005 Feb;76(2):181-5. doi: 10.1136/jnnp.2003.034843.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验